UHT

UHT is an income vehicle, not a growth story, and the numbers say so plainly. Revenue was dead flat at $99.2M (+0.2% YoY) while net income fell -8.4% to $17.6M and diluted EPS slipped -8.6% to $1.27 — the fifth straight year of essentially no top-line progress ($95.6M→$99.0M→$99.2M) with earnings drifting the wrong way. The headline 36.1x P/E is misleading for a REIT: adding back $28.9M of D&A to $17.6M net income implies roughly $46M of FFO (~$3.3/share), so the stock trades near ~14x FFO — a fair, unremarkable multiple for a low-growth healthcare landlord. Operating cash flow of $49.1M (+4.6%) comfortably funds the $41.0M dividend, giving a ~6.4% yield that is the core reason to own this at all.

The balance sheet is the yellow flag. Stockholders' equity fell -15.1% to $152M because the trust pays out more than it earns ($41.0M dividends vs $17.6M net income), and liabilities/equity has climbed to 2.71x against $375M of long-term debt. Management is explicit that the run-up in rates has 'significantly increased our interest expense thereby reducing our net income, cash provided by operating activities and funds from operations' — with only $6.7M of cash, refinancing and swap/cap terms are a live drag on the very FFO that covers the dividend.